Elizabeth Plimack, MD, MS
- Request Appointment
- Clinical Locations
- Education, Training & Credentials
- Patient Stories
- Research Profile
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Chief, Division of Genitourinary Medical Oncology
Director, Genitourinary Clinical Research
Associate Professor, Department of Hematology/Oncology
NCCN, Bladder/Penile Cancers Panel Member
NCCN, Kidney Cancer Panel Member
NCCN, Prostate Cancer Panel Member
With a diagnosis of cancer comes uncertainty and fear for many patients. As a medical oncologist, my first job is to help each patient understand his or her diagnosis. With that understanding, together we can design the best plan of action. At Fox Chase, each patient has the benefit of an interdisciplinary team working together to ensure the highest quality care. This interdisciplinary approach is crucial in determining and implementing the best treatment plan.
I specialize in the treatment of kidney, bladder, prostate and testicular cancer, and my clinical practice is focused on these diseases. By concentrating exclusively on genitourinary malignancies I am able to offer expert knowledge as well as access to both standard treatments and emerging therapies in the form of clinical trials. The pace of scientific discovery has accelerated in recent decades, and fortunately we have seen these discoveries translate into meaningful improvements in cancer treatments.
As part of the genitourinary group here at Fox Chase, I am proud to be a part of a team of distinguished researchers who have pioneered many of these new treatments. My particular research efforts focus on the development of new therapies for bladder and kidney cancer.
- Chief Fellow, Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
- Intern and Resident, Internal Medicine, New York University Medical Center / Bellevue Hospital, NY
- MS, Patient-Based Biologic Research, University of Texas Graduate School of Biomedical Sciences, 2008
- MD with Honors in Pathology, New York University School of Medicine, 2002
- National Comprehensive Cancer Network (NCCN)
- Bladder/Penile Cancers Panel
- Kidney/Testicular Cancers Panel
- Prostate Cancer Panel
- American Society of Clinical Oncology
Honors & Awards
- Leadership Forum Excellence Award, Fox Chase Cancer Center, 2012
- Humanitas Award, Division of Cancer Medicine Hematology/Oncology Fellowship, MD Anderson Cancer Center, 2008
- Award for Achievement in Clinical Investigation, Division of Cancer Medicine, MD Anderson Cancer Center, 2008
- Research Forum, MD Anderson Cancer Center, 2008
- Honorable Mention, First Annual Hematology/Oncology Fellowship Program, 2008
- ASCO Foundation Merit Award, ASCO Genitourinary Cancers Symposium, 2008
One morning in early October of 2012, Michael Fenick noticed blood in his urine. “I immediately called my primary care physician, Dr. James Sheerer, who then sent me for a urinalysis that day. He also prescribed an antibiotic as he suspected it may have been some type of infection,” recalls Michael. A few days later, Michael was sent for a second urinalysis and that test showed microscopic blood still in his urine not visible to the naked eye.
In July 2012, Kevin Galligan returned from a business trip to the Middle East with a respiratory infection and a bad cough. His internist prescribed an antibiotic and suggested a chest X-Ray. After several days on the drug, the cough and related symptoms were gone and Kevin was feeling well. The following week, Kevin’s doctor called with the X-Ray results, pointing out an issue on his right lung. Kevin promptly met with a pulmonologist.
Ted Ritter, a mechanical engineer, spent 20 years running his own business. He spent the last 10 administrating a small municipality in South Jersey. During this time, he and his wife, Sheila, raised four children. In January 2010, Ted, who was 66, retired, moving forward to the next chapter of his life which was to include time in Florida, golf, exercise and some part-time work. But life doesn't always cooperate with your plans.
In February 2012, Marcia Renouf, 65, noticed blood in her urine. Knowing that was cause for concern, she quickly called her primary care physician. “My only symptom was blood in the urine. I saw my doctor that morning and had an ultrasound that afternoon,” Marcia recalls.
Following her ultrasound, Marcia was referred to a local urologist for additional testing. She and her husband, John, traveled to the urologist who performed a same day cystoscopy, which revealed a tumor in her bladder.
In March 2009, New Jersey police officer Peter Hagerty was experiencing groin pain when he was getting in and out of his patrol car. Like many men his age, Peter shrugged it off for two weeks. By the third week, after realizing his testicle was rock hard, Peter told his wife, Eryn, an advanced life support paramedic. "Eryn sent me right to the doctor," recalled Peter, whose primary doctor referred him directly to a urologist. An ultrasound performed later the same day showed a tumor and the doctor suspected it was cancer.
- Biomarkers predictive of response to neoadjuvant cisplatin based chemotherapy in bladder cancer
- Refining neoadjuvant chemotherapy regimens for bladder cancer
- Developmental Therapeutics – early stage clinical trials of novel agents
- Immunotherapy in GU Malignancies